Tramadol: A Double-Edged Sword Impact on the Brain and Body

Course overview

Tramadol, a synthetic Schedule IV opioid, offers pain relief through u-opioid receptor agonism and serotonin-norepinephrine reuptake inhibition. While considered a weak opioid, it carries risks of sedation and seizures. Some medical experts refer to the use of tramadol as a "double-edged sword" because although it can act as an antidepressant, it also increases the risk of serotonin syndrome when used alongside other antidepressant treatments. Dosing adjustments are critical in hepatic or renal impairment and require close monitoring for people with both conditions. Although the potential for misuse is lower than that of stronger opioids, tramadol overdose can lead to serious morbidity and mortality, highlighting the importance of cautious prescribing and patient education.